Immunopotentiation is a topic in immunology that is attracting increasing interest. In this field, oil adjuvants have proved their superiority and Freund et al. (10) have shown that the addition of some bacteria, such as mycobacte ria, to such oil adjuvants improves their immunopotentiating effect.
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Current studies carried out in our laboratory on crystal violet treated C. ovis have clearly shown its capacity as a non-specific immune stimulant, capable of raising the resistance of sheep to artificial infection with potential pathogens, in a manner comparable with that produced by BCG (5, 6) .
It was decided to test the formalin-killed C. ovis for its immunopotentiat ing ability when used as an adjuvant with inert antigens and killed microbial vaccines.
separate groups of 30 for each vaccine formula. At 10-days intervals, 5 ani mals from each group were sacrificed and their sera were pooled for determination of antibody levels by the suitable serological tests.
Antigens.
The following antigens were used :
(a) Egg albumin, from Sigma Chemical Company, USA, was used as a soluble antigen.
(b) Foot and mouth disease (FMD) virus vaccine type 0 ] , a local Egyp tian strain that was inactivated by acetylethyleneimine according to Brown and Crick (7) . Each guinea pig was inoculated with 2 ml of 10 7 TCID 50 per ml subcutaneously.
(c) Salmonella typhimurium, a local isolate that was killed with 0.5% for malin. The adjuvant was added to a bacterial suspension of 10 9 cells per ml, and 2 ml of the mixture were injected subcutaneously into guinea pigs according to Hunter and Peek (12) and Bairey (1) .
Adjuvants.
(a) Corynebacterium ovis, a local strain that was isolated from a native sheep, identified morphologically, biochemically and biologically (9) and stored freeze-dried at the Animal Health Research Institute, Dokki, Giza, Egypt, as a reference strain.
This strain was injected subcutaneously into guinea pigs to produce abscess formation at the site of inoculation for activation of the microorganism. Pus from the abscess was streaked on blood agar that revealed pure C. ovis. For quantitative cell production, C. ovis was plated onto heart infusion agar in Roux bottles, incubated for 48 hours and swabbed into saline. The cells were killed by 0.5% formalin, washed thrice, weighed and stored in saline at 4°C until use.
Crystal violet treated C. ovis is an attenuated strain, which was used in other studies on the same principles as BCG, with the purpose to have a good substitute for BCG to avoid tuberculin sensitivity. 
Methods.
(a) The immune response against FMD and egg albumin was measured by the complement fixation test (CFT) after Traub and Pyl (19) . End points were calculated according to Kärber (14) .
(b) The tube agglutination test, according to Kauffmann (15) , was used to determine quantitatively the Salmonella-specific antibodies in sera of vaccin ated animals.
RESULTS
The studies presented here include four experiments :
1. The first experiment was designed to test C. ovis for its immunopoten tiating activity when used with a standard antigen like egg albumin, and to determine the optimal dose leading to the maximal immune response. The results of this experiment are shown in Table I. 2. The second experiment aimed, by adding an oil base to C. ovis, to improve its immunopotentiating effect. Freund's incomplete adjuvant was chosen for that purpose, and was mixed with different concentrations of kil led C. ovis. The resulting immune responses were compared with that elicited when using Freund's complete adjuvant as an immunopotentiator. The results of this experiment are shown in Table II. 3. The third and fourth experiments were designed to illustrate the adju vant effect of C. ovis when used with FMD and Salmonella killed vaccines. The results of using C. ovis alone or C. ovis with incomplete Freund's adju vant are presented in comparison with complete Freund's adjuvant in Tables  III and IV. 
DISCUSSION
By immunopotentiation is meant an increase in the intensity of the immune response, prolongation of its duration or even the development of a response to an otherwise non-immunogenic substance. There is a continuous search for such immunopotentiators or adjuvants to enhance the immune res ponse of killed vaccines in the human and veterinary medical fields.
C. ovis has been extensively studied in our laboratory, and its properties as a non-specific immune stimulant have been proved. In this paper, we introduced it as an adjuvant giving some light on its immunopotentiating capacity (2, 3, 4) .
From Table I , it is clear that the addition of formalin-killed C. ovis to egg albumin increased the resulting immune response of inoculated guinea pigs, both in its intensity and duration. The best response was obtained when using 400 mg of C. ovis, while higher and lower doses were less satisfactory. In other words, the resulting immune response is roughly proportional to the amount of C. ovis incorporated in the vaccine till a certain optimal concen tration is reached, in this case 400 mg, beyond which some sort of a blockage effect holds.
In the second experiment, we thought of adding an oil base to C. ovis in an attempt to increase its immunopotentiating effect. For this purpose, incomplete Freund's adjuvant was chosen. Results given in Table II show that the incorporation of only 300 mg of C. ovis with incomplete Freund's C stands for C. ovis and is followed by the dose used in mg. DPV : Days post vaccination. 
Type of inoculum

S. typhimurium
DPV
TABLE IV
The adjuvant effect of C. ovis and Freund's adjuvants on the antibody response to Salmonella typhimurium adjuvant was quite enough to produce the maximal immune response. It is also clear that the C. ovis-incomplete Freund's adjuvant mixture elicited a better response than did the incomplete Freund's adjuvant alone or even the complete adjuvant. In other words, formalin-killed C. ovis seems to be supe rior to killed mycobacteria in its immunopotentiating effect, on some anti gens at least.
In the third and fourth experiments, we studied the use of C. ovis as an adjuvant with killed vaccines for two potential pathogens of veterinary inte rest, namely FMD virus and Salmonella typhimurium.
The results obtained, as shown in Tables III and IV respectively, demonstrate clearly the stimul atory effect of C. ovis. It is clear that the best response can be obtained by using 300 mg of C. ovis alone as an adjuvant or when mixed with incomplete Freund's adjuvant. The response was superior to that obtained by Freund's complete adjuvant. As shown in the same tables, mixing Salmonella and FMD antigens together with the optimal dose of C. ovis resulted in a poten tiation in the immune response to Salmonella at the expense of FMD. This may be explained according to the antigenic concurrence phenomenon (18) .
From the above data, it is clear that formalin-killed C. ovis has a good immunopotentiating effect on a standard soluble antigen as well as bacterial and viral particulate antigens, which justifies its proposal as an adjuvant to killed vaccines. The organism can be used either alone or mixed with incom plete Freund's adjuvant, the optimal dose being 400 and 300 mg, respect ively. It seems here that the waxy material in C. ovis structure (13) contribu tes efficiently to the stimulation of antibody production in a similar way and rather superior to the waxes of mycobacteria (Malcolm et al., 1979) associat ed with Freund's complete adjuvant. Besides, the use of C. ovis did not entangle risks of antigenic denaturation as seen by the use of Freund's com plete adjuvant (20) .
Moreover, the use of Freund's complete adjuvant may sensitize the host to react non-specifically when the animal is tuberculin-tested as an essential step in the measures for tuberculosis control. Stimulation of cross-reactivity to tuberculin by C. ovis has not been established. Studies are in progress to investigate the sensitivity of C. ovis-infected sheep and bovines to tuberculin.
Another advantage is the specific immunization provoked also by C. ovis adjuvant against Corynebacterium ovis infection in sheep, cattle and buffa loes, taking into account that immunity to C. ovis is mainly cellular (11, 8) , and that there is no reliable serological test until now for its diagnosis (17) .
Finally, we think that a better immune response might be obtained if the principal adjuvant component of C. ovis could be isolated, identified and used in a pure form. 
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